1-12 of 12
Rita Nahta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B05: Mechanisms of PPM1D-mediated tumorigenesis in diffuse intrinsic pontine glioma (DIPG)

Free
Mwangala P. Akamandisa, Kai Nie, Jing Wen, Rita Nahta, Dolores Hambardzumyan, Robert C. Castellino
Journal: Cancer Research
Cancer Res (2018) 78 (19_Supplement): B05.
https://doi.org/10.1158/1538-7445.PEDCA17-B05
Published: 01 October 2018
View articletitled, Abstract B05: Mechanisms of PPM1D-mediated tumorigenesis in diffuse intrinsic pontine glioma (DIPG)
Journal Articles

Abstract 889: Growth differentiation factor 15 causes increased invasiveness and EMT in HER2-overexpressing breast cancer via activation of p38 MAPK.

Free
Jayashree P. Joshi, Zhengjia Chen, Rita Nahta
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 889.
https://doi.org/10.1158/1538-7445.AM2013-889
Published: 15 April 2013
View articletitled, Abstract 889: Growth differentiation factor 15 causes increased invasiveness and EMT in HER2-overexpressing breast cancer via activation of p38 MAPK.
Journal Articles

Abstract P4-07-02: Growth differentiation factor 15, a novel mediator of progression in HER2-positive breast cancer

Free
Rita Nahta, Jayashree P Joshi, Samantha E Griner, Amy L Adams, Fabrice Andre
Journal: Cancer Research
Cancer Res (2012) 72 (24_Supplement): P4-07-02.
https://doi.org/10.1158/0008-5472.SABCS12-P4-07-02
Published: 15 December 2012
View articletitled, Abstract P4-07-02: Growth differentiation factor 15, a novel mediator of progression in HER2-positive breast cancer
Journal Articles

Abstract 2703: Final results of a phase 2 trial using a novel, non-anthracycline neoadjuvant chemotherapy regimen in Her2-positive breast cancer

Free
Ruth M. O'Regan, Sheryl Gabram, Toncred Styblo, Monica Rizzo, William Wood, Jayanthi Srinivasiah, William Jonas, Fred Schnell, Amy Adams, Rita Nahta, Amelia Zelnak
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2703.
https://doi.org/10.1158/1538-7445.AM2012-2703
Published: 15 April 2012
View articletitled, Abstract 2703: Final results of a phase 2 trial using a novel, non-anthracycline neoadjuvant chemotherapy regimen in Her2-positive breast cancer
Journal Articles

Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism

Free
Yuhua Zhao, Hao Liu, Zixing Liu, Yan Ding, Susan P. LeDoux, Glenn L. Wilson, Richard Voellmy, Yifeng Lin, Wensheng Lin, Rita Nahta, Bolin Liu, Oystein Fodstad, Jieqing Chen, Yun Wu, Janet E. Price, Ming Tan
Journal: Cancer Research
Cancer Res (2011) 71 (13): 4585–4597.
https://doi.org/10.1158/0008-5472.CAN-11-0127
Published: 30 June 2011
View articletitled, Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism
Open the PDF for Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism in another window
Includes: Supplementary data
Journal Articles

The dual EGFR/HER-2 kinase inhibitor lapatinib induces apoptosis and potentiates anti-IGF-IR therapy in trastuzumab-resistant breast cancer cells

Free
Rita Nahta, Linda Xh Yuan, Francisco J. Esteva
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1116.
Published: 15 April 2006
View articletitled, The dual EGFR/HER-2 kinase inhibitor lapatinib induces apoptosis and potentiates anti-IGF-IR therapy in trastuzumab-resistant breast cancer cells
Journal Articles

Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma.

Free
Hiroaki Itamochi, Junzo Kigawa, Yasunobu Kanamori, Tetsuro Oishi, Chandra Bartholomeusz, Rita Nahta, Francisco J. Esteva, Nour Sneige, Naoki Terakawa, Naoto T. Ueno
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1289–1290.
Published: 15 April 2006
View articletitled, Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma.
Journal Articles

Insulin-like Growth Factor-I Receptor/Human Epidermal Growth Factor Receptor 2 Heterodimerization Contributes to Trastuzumab Resistance of Breast Cancer Cells

Free
Rita Nahta, Linda X.H. Yuan, Bing Zhang, Ryuji Kobayashi, Francisco J. Esteva
Journal: Cancer Research
Cancer Res (2005) 65 (23): 11118–11128.
https://doi.org/10.1158/0008-5472.CAN-04-3841
Published: 01 December 2005
View articletitled, Insulin-like Growth Factor-I Receptor/Human Epidermal Growth Factor Receptor 2 Heterodimerization Contributes to Trastuzumab Resistance of Breast Cancer Cells
Open the PDF for Insulin-like Growth Factor-I Receptor/Human Epidermal Growth Factor Receptor 2 Heterodimerization Contributes to Trastuzumab Resistance of Breast Cancer Cells in another window
Journal Articles

P27kip1 Down-Regulation Is Associated with Trastuzumab Resistance in Breast Cancer Cells

Free
Rita Nahta, Takeshi Takahashi, Naoto T. Ueno, Mien-Chie Hung, Francisco J. Esteva
Journal: Cancer Research
Cancer Res (2004) 64 (11): 3981–3986.
https://doi.org/10.1158/0008-5472.CAN-03-3900
Published: 01 June 2004
View articletitled, P27kip1 Down-Regulation Is Associated with Trastuzumab Resistance in Breast Cancer Cells
Open the PDF for P27kip1 Down-Regulation Is Associated with Trastuzumab Resistance in Breast Cancer Cells in another window
Journal Articles

The HER-2-Targeting Antibodies Trastuzumab and Pertuzumab Synergistically Inhibit the Survival of Breast Cancer Cells

Free
Rita Nahta, Mien-Chie Hung, Francisco J. Esteva
Journal: Cancer Research
Cancer Res (2004) 64 (7): 2343–2346.
https://doi.org/10.1158/0008-5472.CAN-03-3856
Published: 01 April 2004
View articletitled, The HER-2-Targeting Antibodies Trastuzumab and Pertuzumab Synergistically Inhibit the Survival of Breast Cancer Cells
Open the PDF for The HER-2-Targeting Antibodies Trastuzumab and Pertuzumab Synergistically Inhibit the Survival of Breast Cancer Cells in another window
Journal Articles

Epidermal Growth Factor Receptor Expression Is a Candidate Target of the Synergistic Combination of Trastuzumab and Flavopiridol in Breast Cancer

Free
Rita Nahta, Sally Trent, Chuanwei Yang, Emmett V. Schmidt
Journal: Cancer Research
Cancer Res (2003) 63 (13): 3626–3631.
Published: 01 July 2003
View articletitled, Epidermal Growth Factor Receptor Expression Is a Candidate Target of the Synergistic Combination of Trastuzumab and Flavopiridol in Breast Cancer
Open the PDF for Epidermal Growth Factor Receptor Expression Is a Candidate Target of the Synergistic Combination of Trastuzumab and Flavopiridol in Breast Cancer in another window
Journal Articles

Rate-limiting Effects of Cyclin D1 in Transformation by ErbB2 Predicts Synergy between Herceptin and Flavopiridol

Free
Rita Nahta, J. Dirk Iglehart, Bettina Kempkes, Emmett V. Schmidt
Journal: Cancer Research
Cancer Res (2002) 62 (8): 2267–2271.
Published: 01 April 2002
View articletitled, Rate-limiting Effects of Cyclin D1 in Transformation by ErbB2 Predicts Synergy between Herceptin and Flavopiridol
Open the PDF for Rate-limiting Effects of Cyclin D1 in Transformation by ErbB2 Predicts Synergy between Herceptin and Flavopiridol in another window